Stock-based compensation

3 Months Ended

Apr. 30, 2014

Stock-based compensation [Abstract]

Stock-based compensation [Text Block]

Stock-basedcompensation. The Company has stock-based compensation awards that can be granted to eligible employees, officers or directors.

	Three Months Ended April 30,
	2014			2013
Stock-based compensation (benefit) expense		($381	)		$119
Restricted stock based compensation expense		($69	)		$—

Stock-based compensation was a benefit in the current period due to cancellations. Most of these cancellations related to former employees from the discontinued operations.

The fair value of the outstanding option awards was estimated on the grant dates using the Black-Scholes option pricing model.

	Three Months Ended April 30,
Fair value assumptions	2014	2013
Expected volatility	42.12% - 60.26%	53.90% - 65.54%
Risk free interest rate	.74% - 2.19%	.74% - 2.82%
Dividend yield	none	none
Expected life	4.9 - 5.7 years	4.9 - 5.7 years

Option activity	Options		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Term in Years	Aggregate Intrinsic Value
Outstanding at January 31, 2014	776			$11.69	6.1		$3,859
Exercised	(22	)	7.40			1,082
Expired or forfeited	(47	)	20.64
Outstanding end of period	707		11.23		5.9	1,697
Exercisable end of period	449			$12.91	4.6		$1,023

Unvested option activity	Unvested Options Outstanding		Weighted Average Exercise Price Per Share		Aggregate Intrinsic Value
Outstanding at January 31, 2014	263			$8.31		$1,633
Expired or forfeited	(5	)	8.24
Outstanding end of period	258			$8.31		$673

As of April 30, 2014, there was $0.8 million of total unrecognized compensation expense related to unvested stock options. The expense is expected to be recognized over a period of 2.2 years.

Restricted stock

There was no activity related to the restricted stock during the current year. As of April 30, 2014, there was $0.1 million of unrecognized compensation expense related to unvested restricted stock granted under the plans. The cost is expected to be recognized over the weighted-average period of 1.2 years.